Japan Cough Syrup Market Forecast 2023-2030

The Japan cough syrup market is set to grow at a CAGR of 4.19% during the forecast period, 2023-2030. The market growth is driven by the increasing air pollution, changing lifestyles, and a growing awareness of healthcare. In addition, cough syrup manufacturers in Japan are focusing on research and development to introduce innovative formulations and expand their product portfolios.

REGIONAL INSIGHTS

Japan has a robust national healthcare policy that underscores the importance of making healthcare items, such as medications, economical and easily obtainable for all its citizens. The government actively oversees drug prices, promotes the utilization of generic medicines, and engages in negotiations with pharmaceutical companies to manage healthcare expenses. This strategy ensures that cough syrups and other vital medications remain accessible to both the elderly and the general population.

Furthermore, the presence of reasonably priced and readily accessible healthcare products aligns with Japan's healthcare system, which places a strong emphasis on preventive measures and early intervention. Japanese citizens are encouraged to promptly seek medical attention and treatment for common ailments, which includes the utilization of over-the-counter cough syrups for addressing mild respiratory symptoms. Moreover, the Ministry of Health, Labour and Welfare (MHLW) oversees pharmaceutical products in Japan. It enforces stringent regulations to ensure the quality, safety, and efficacy of cough syrup products, assuring consumers of their reliability.

COMPETITIVE INSIGHTS

Some of the eminent companies in the market include: GSK plc, Procter & Gamble, Reckitt Benckiser Group PLC, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 71419

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. SCOPE OF STUDY
2.5. CRISIS SCENARIO ANALYSIS
- 2.5.1. IMPACT OF COVID-19 ON COUGH SYRUP MARKET
- 2.5.2. IMPACT OF THE RUSSIA-UKRAINE WAR ON COUGH SYRUP MARKET
2.6. MAJOR MARKET FINDINGS
- 2.6.1. PRODUCT DIVERSIFICATION IS ON THE RISE
- 2.6.2. DOMINANCE OF OTC COUGH SYRUPS HAS DRIVEN ACCESSIBILITY
- 2.6.3. HEALTHCARE INFORMATION AVAILABILITY ON DIGITAL PLATFORMS INFLUENCES CONSUMER CHOICES

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. PREVALENCE OF RESPIRATORY AILMENTS
- 3.1.2. RISING GERIATRIC POPULATION
- 3.1.3. INNOVATIONS IN COUGH SYRUPS
3.2. KEY RESTRAINTS
- 3.2.1. OVER-DOSAGE CONCERNS DRIVING CONSUMERS TOWARD ALTERNATIVES
- 3.2.2. STRINGENT REGULATORY PROTOCOLS
- 3.2.3. INCREASING CASES OF COUGH SYRUP DEATHS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. INCREASING SELF-MEDICATION TRENDS
- 4.1.2. SHIFTING CONSUMER PREFERENCE TOWARD HERBAL COUGH SYRUPS
- 4.1.3. RISING POPULARITY OF E-COMMERCE CHANNELS
- 4.1.4. COMPANIES ARE OFFERING SUGAR-FREE COUGH SYRUPS
- 4.1.5. GROWING INCLINATION TOWARD HOMEOPATHIC COUGH SYRUPS
4.2. PEST ANALYSIS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
- 4.4.1. GROWTH PROSPECT MAPPING FOR JAPAN
4.5. VALUE CHAIN ANALYSIS

5. MARKET BY PRODUCT TYPE

5.1. COUGH SUPPRESSANTS
- 5.1.1. MARKET FORECAST FIGURE
- 5.1.2. SEGMENT ANALYSIS
5.2. COMBINATION MEDICINES
- 5.2.1. MARKET FORECAST FIGURE
- 5.2.2. SEGMENT ANALYSIS
5.3. EXPECTORANTS
- 5.3.1. MARKET FORECAST FIGURE
- 5.3.2. SEGMENT ANALYSIS

6. MARKET BY AGE GROUP

6.1. ADULTS
- 6.1.1. MARKET FORECAST FIGURE
- 6.1.2. SEGMENT ANALYSIS
6.2. ADOLESCENTS
- 6.2.1. MARKET FORECAST FIGURE
- 6.2.2. SEGMENT ANALYSIS
6.3. PEDIATRIC
- 6.3.1. MARKET FORECAST FIGURE
- 6.3.2. SEGMENT ANALYSIS

7. MARKET BY DISTRIBUTION CHANNEL

7.1. RETAIL PHARMACIES
- 7.1.1. MARKET FORECAST FIGURE
- 7.1.2. SEGMENT ANALYSIS
7.2. HOSPITAL PHARMACIES
- 7.2.1. MARKET FORECAST FIGURE
- 7.2.2. SEGMENT ANALYSIS
7.3. E-PHARMACIES
- 7.3.1. MARKET FORECAST FIGURE
- 7.3.2. SEGMENT ANALYSIS

8. COMPETITIVE LANDSCAPE

8.1. KEY STRATEGIC DEVELOPMENTS
- 8.1.1. MERGERS & ACQUISITIONS
- 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 8.1.3. PARTNERSHIPS & AGREEMENTS
- 8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
- 8.2.1. GSK PLC
  - 8.2.1.1. COMPANY OVERVIEW
  - 8.2.1.2. PRODUCT LIST
  - 8.2.1.3. STRENGTHS & CHALLENGES
- 8.2.2. NOVARTIS AG
  - 8.2.2.1. COMPANY OVERVIEW
  - 8.2.2.2. PRODUCT LIST
  - 8.2.2.3. STRENGTHS & CHALLENGES
- 8.2.3. PFIZER INC
  - 8.2.3.1. COMPANY OVERVIEW
  - 8.2.3.2. PRODUCT LIST
  - 8.2.3.3. STRENGTHS & CHALLENGES
- 8.2.4. PROCTER & GAMBLE
  - 8.2.4.1. COMPANY OVERVIEW
  - 8.2.4.2. PRODUCT LIST
  - 8.2.4.3. STRENGTHS & CHALLENGES
- 8.2.5. RECKITT BENCKISER GROUP PLC
  - 8.2.5.1. COMPANY OVERVIEW
  - 8.2.5.2. PRODUCT LIST
  - 8.2.5.3. STRENGTHS & CHALLENGES

Product Code: 71419

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - COUGH SYRUP MARKET
TABLE 2: JAPAN COUGH SYRUP MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: JAPAN COUGH SYRUP MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 4: JAPAN COUGH SYRUP MARKET, BY AGE GROUP, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: JAPAN COUGH SYRUP MARKET, BY AGE GROUP, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 6: JAPAN COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: JAPAN COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 8: JAPAN COUGH SYRUP MARKET REGULATORY FRAMEWORK
TABLE 9: KEY PLAYERS OPERATING IN JAPAN COUGH SYRUP MARKET
TABLE 10: LIST OF MERGERS & ACQUISITIONS
TABLE 11: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 12: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 13: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR JAPAN
FIGURE 4: VALUE CHAIN ANALYSIS
FIGURE 5: JAPAN COUGH SYRUP MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2022
FIGURE 6: JAPAN COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2030 (IN $ MILLION)
FIGURE 7: JAPAN COUGH SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2030 (IN $ MILLION)
FIGURE 8: JAPAN COUGH SYRUP MARKET, BY EXPECTORANTS, 2023-2030 (IN $ MILLION)
FIGURE 9: JAPAN COUGH SYRUP MARKET, GROWTH POTENTIAL, BY AGE GROUP, IN 2022
FIGURE 10: JAPAN COUGH SYRUP MARKET, BY ADULTS, 2023-2030 (IN $ MILLION)
FIGURE 11: JAPAN COUGH SYRUP MARKET, BY ADOLESCENTS, 2023-2030 (IN $ MILLION)
FIGURE 12: JAPAN COUGH SYRUP MARKET, BY PEDIATRIC, 2023-2030 (IN $ MILLION)
FIGURE 13: JAPAN COUGH SYRUP MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2022
FIGURE 14: JAPAN COUGH SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2030 (IN $ MILLION)
FIGURE 15: JAPAN COUGH SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2030 (IN $ MILLION)
FIGURE 16: JAPAN COUGH SYRUP MARKET, BY E-PHARMACIES, 2023-2030 (IN $ MILLION)